<ARTICLE> 5 <CIK> 0000763098 <NAME> RESPONSE ONCOLOGY <MULTIPLIER> 1,000 <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> SEP-30-2000 <EXCHANGE-RATE> 1 <CASH> 7,857 <SECURITIES> 0 <RECEIVABLES> 13,894 <ALLOWANCES> 2,602 <INVENTORY> 2,960 <CURRENT-ASSETS> 42,510 <PP&E> 17,071 <DEPRECIATION> 13,470 <TOTAL-ASSETS> 109,967 <CURRENT-LIABILITIES> 51,851 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 17 <COMMON> 123 <OTHER-SE> 46,306 <TOTAL-LIABILITY-AND-EQUITY> 109,967 <SALES> 99,952 <TOTAL-REVENUES> 99,952 <CGS> 68,450 <TOTAL-COSTS> 101,700 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 405 <INTEREST-EXPENSE> 2,548 <INCOME-PRETAX> (2,193) <INCOME-TAX> (830) <INCOME-CONTINUING> (1,363) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,363) <EPS-BASIC> (.11) <EPS-DILUTED> (.11)